Abacus Life, Inc.
Abacus Life, Inc. (ABLLW) Financial Performance & Income Statement Overview
Analyze Abacus Life, Inc. (ABLLW) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Abacus Life, Inc. (ABLLW) Income Statement & Financial Overview
Analyze Abacus Life, Inc.’s ABLLW earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $44.14M | $33.21M | $28.15M | $29.93M |
| Cost of Revenue | $7.11M | $3.72M | $2.19M | $2.74M |
| Gross Profit | $37.03M | $29.49M | $25.96M | $25.44M |
| Gross Profit Ratio | $0.84 | $0.89 | $0.92 | $0.85 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $14.88M | $42.75M | $17.66M | $17.11M |
| Operating Expenses | $14.88M | $46.25M | $19.11M | $19.56M |
| Total Costs & Expenses | $21.99M | $49.97M | $21.30M | $22.31M |
| Interest Income | $1.18M | $727863.00 | $609496.00 | $639906.00 |
| Interest Expense | $9.62M | $5.86M | $4.22M | $4.53M |
| Depreciation & Amortization | $4.76M | $2.73M | $1.75M | $1.75M |
| EBITDA | $22.11M | -$7.61M | $428414.00 | $8.52M |
| EBITDA Ratio | $0.50 | -$0.23 | $0.02 | $0.28 |
| Operating Income | $21.03M | -$16.76M | $6.85M | $6.77M |
| Operating Income Ratio | $0.48 | -$0.50 | $0.24 | $0.23 |
| Other Income/Expenses (Net) | -$13.29M | $556553.00 | -$12.39M | -$4.36M |
| Income Before Tax | $7.73M | -$16.21M | -$5.54M | $2.41M |
| Income Before Tax Ratio | $0.18 | -$0.49 | -$0.20 | $0.08 |
| Income Tax Expense | $2.33M | $2.80M | -$250368.00 | $1.76M |
| Net Income | $4.64M | -$18.26M | -$5.13M | $769983.00 |
| Net Income Ratio | $0.11 | -$0.55 | -$0.18 | $0.03 |
| EPS | $0.05 | -$0.24 | -$0.07 | $0.01 |
| Diluted EPS | $0.05 | -$0.24 | -$0.07 | $0.01 |
| Weighted Avg Shares Outstanding | $96.19M | $81.78M | $74.69M | $63.85M |
| Weighted Avg Shares Outstanding (Diluted) | $97.50M | $81.78M | $74.69M | $67.16M |
The company's financials show resilient growth, with revenue advancing from $29.93M in Q2 2024 to $44.14M in Q1 2025. Gross profit remained healthy with margins at 84% in Q1 2025 compared to 85% in Q2 2024. Operating income hit $21.03M last quarter, sustaining a consistent 48% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $22.11M. Net income rose to $4.64M, while earnings per share reached $0.05. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan